GA
Healthcare & Life Sciences
GLYCART biotechnology AG
Switzerland
GLYCART biotechnology AG is a Healthcare & Life Sciences startup based in Switzerland, since acquired.
Acquiredacquired
acquired
Stage
About GLYCART biotechnology AG
GLYCART biotechnology AG is a company headquartered in Switzerland. GLYCART biotechnology AG has been acquired. Brouky classifies it under Healthcare & Life Sciences.
GLYCART biotechnology AG was a Swiss biotechnology company that developed engineered glyco-engineered antibody-based therapeutics targeting unmet clinical needs such as cancer. The company was acquired by Roche in 2005 for CHF 230 million.
Explore GLYCART biotechnology AG's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.